DEA schedule
Is remifentanil a controlled substance?
Federal schedule for remifentanil from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Remifentanil is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Remifentanil (Schedule II).
Run it in Rivvi
Which 2027 plans near you dropped or restricted remifentanil?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 13 prescription listings from 3 labelers, all Schedule II |
| DEA controlled substances list | Remifentanil: Schedule II |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Remifentanil | 9739 | II | Yes | Ultiva | Listed by name |
Remifentanil NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 67457-912 | Ultiva | injection, powder, lyophilized, for solution | 1 mg/mL | Mylan Institutional LLC | CII |
| 67457-913 | Ultiva | injection, powder, lyophilized, for solution | 1 mg/mL | Mylan Institutional LLC | CII |
| 67457-914 | Ultiva | injection, powder, lyophilized, for solution | 1 mg/mL | Mylan Institutional LLC | CII |
| 72078-034 | Ultiva | injection, powder, lyophilized, for solution | 1 mg/mL | Mylan Institutional LLC | CII |
| 72078-035 | Ultiva | injection, powder, lyophilized, for solution | 1 mg/mL | Mylan Institutional LLC | CII |
| 72078-036 | Ultiva | injection, powder, lyophilized, for solution | 1 mg/mL | Mylan Institutional LLC | CII |
| 0143-9391 | REMIFENTANIL HYDROCHLORIDE | injection, powder, lyophilized, for solution | 1 mg/mL | Hikma Pharmaceuticals USA Inc. | CII |
| 63323-723 | Remifentanil Hydrochloride | injection, powder, lyophilized, for solution | 1 mg/mL | Fresenius Kabi USA, LLC | CII |
| 63323-723 | Remifentanil Hydrochloride | injection, powder, lyophilized, for solution | 1 mg/mL | Fresenius Kabi USA, LLC | CII |
| 63323-724 | Remifentanil Hydrochloride | injection, powder, lyophilized, for solution | 1 mg/mL | Fresenius Kabi USA, LLC | CII |
| 63323-725 | Remifentanil Hydrochloride | injection, powder, lyophilized, for solution | 1 mg/mL | Fresenius Kabi USA, LLC | CII |
| 0143-9392 | REMIFENTANIL HYDROCHLORIDE | injection, powder, lyophilized, for solution | 2 mg/2mL | Hikma Pharmaceuticals USA Inc. | CII |
| 0143-9393 | REMIFENTANIL HYDROCHLORIDE | injection, powder, lyophilized, for solution | 5 mg/5mL | Hikma Pharmaceuticals USA Inc. | CII |
Questions
Is remifentanil a controlled substance?
Yes. Remifentanil is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Remifentanil (Schedule II).
Is remifentanil a narcotic?
Yes. The DEA list marks remifentanil as a narcotic (NARC = Y) and places it in Schedule II. Its FDA established pharmacologic class is Opioid Agonist.
What schedule is remifentanil?
Remifentanil is Schedule II in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Remifentanil
- What is Remifentanil used for?FDA label uses
- Generic for UltivaFDA Orange Book
- What is Ultiva used for?FDA label uses
- Is Ultiva a controlled substance?Schedule II
- Opioid Agonists listFDA drug class
- NDC 67457-912Remifentanil NDC record
- NDC 67457-913Remifentanil NDC record
- NDC 67457-914Remifentanil NDC record
- Schedule II drugs listDEA schedule